Arrowhead Pharmaceuticals (ARWR) EPS (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) EPS from Sep 30, 2010 to Mar 31, 2026. The TTM Arrowhead Pharmaceuticals (ARWR) EPS is -$2.16. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Arrowhead Pharmaceuticals (ARWR) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +50.13% |
| 3 Years TTM | +15.02% |
| 5 Years TTM | +15.23% |
| 10 Years TTM | +4.80% |
| All Time TTM | +11.40% |
Annual EPS change of Arrowhead Pharmaceuticals (ARWR)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.94 | +7760.90% |
| 2025 | -$0.01 | -99.75% |
| 2024 | -$4.82 | +151.98% |
| 2023 | -$1.91 | +15.12% |
| 2022 | -$1.66 | +23.07% |
| 2021 | -$1.35 | +63.47% |
| 2020 | -$0.83 | -216.05% |
| 2019 | $0.71 | +423.15% |
| 2018 | $0.14 | -177.07% |
| 2017 | -$0.18 | +1.82% |
| 2016 | -$0.17 | -46.41% |
| 2015 | -$0.32 | -21.70% |
| 2014 | -$0.41 | +26.27% |
| 2013 | -$0.33 | -3.63% |
| 2012 | -$0.34 | -6.26% |
| 2011 | -$0.36 | -54.98% |
| 2010 | -$0.80 | N/A |
Comparison Arrowhead Pharmaceuticals (ARWR) five years EPS CAGR with competitors
Arrowhead Pharmaceuticals (ARWR) five years EPS CAGR is 15.23%.